Dainippon Sumitomo Pharma <4506.T>-2008/09 group

May 11 (Reuters) -

DAINIPPON SUMITOMO PHARMA CO LTD

CONSOLIDATED FINANCIAL HIGHLIGHTS

(in billions of yen unless specified)

Year ended Year ended Year to Six months to

Mar 31, 2009 Mar 31, 2008 Mar 31, 2010 Sep 30, 2009

LATEST YEAR-AGO COMPANY COMPANY

RESULTS RESULTS FORECASTS H1 FORECASTS
Sales 264.04 263.99 264.00 130.60

(0.0 pct) (+1.1 pct) (0.0%) (-2.8%)
Operating 31.17 39.81 25.00 12.80

(-21.7 pct) (-12.6 pct) (-19.8%) (-29.6%)
Recurring 31.40 37.66 24.00 12.40

(-16.6 pct) (-12.8 pct) (-23.6%) (-31.9%)
Net 19.99 25.59 15.00 7.80

(-21.9 pct) (+13.2 pct) (-25.0%) (-28.2%)
EPS Y50.30 Y64.39 Y37.75 Y19.63
Annual div Y18.00 Y18.00 Y18.00
-Q2 div Y9.00 Y9.00 Y9.00
-Q4 div Y9.00 Y9.00 Y9.00

NOTE - Dainippon Sumitomo Pharma Co Ltd was formed on Oct. 1, 2005, through the merger of Dainippon Pharmaceutical Co. Ltd. and Sumitomo Pharmaceuticals Co.

For latest earnings estimates made by Toyo Keizai, please
double click on 4506.TK1.